LND topic: obesity-treatment page 1

obesity treatment

Managing Weight and Diabetes: What New Studies on Semaglutide Really Show

May 1, 2026

Research on semaglutide, a once-a-week shot, shows it can help people lose noticeable weight—up to one-sixth of their body weight in some cases. Trials called STEP 1, 3, and 4 focused on adults without diabetes and found weight drops between ten and seventeen percent. For those with type 2 diabetes

health

Less Injections, Same Weight‑Loss Success

March 6, 2026

"It seems you can keep the pounds off while skipping some shots, a new study suggests. Researchers followed 34 people who had already shed weight on GLP‑1 medicines, then let them stretch out their injections. After 36 weeks most stayed lean, with blood pressure and sugar staying lower. Only four pe

health

Keeping the Weight Off: New Insights on GLP-1 Drugs

January 22, 2026

A recent study has some good news for people using GLP-1 drugs like Wegovy or Mounjaro. It suggests that many users may not quickly regain lost weight after stopping treatment. The study looked at data from thousands of patients at U. S. medical clinics. It found that most people either kept the we

business

Wegovy's Strong Start: Novo Nordisk Shares Jump

January 16, 2026

Novo Nordisk's shares got a nice boost on Friday. They went up by more than 5% after some early reports came out. These reports showed that their new obesity pill, Wegovy, is doing well in the U. S. market. The pill, which is the first of its kind for weight loss, had a good start. But experts say

health

The Ozempic Dilemma: Why Stopping Too Soon Can Backfire

January 8, 2026

Obesity drugs like Ozempic and Wegovy are game-changers. They help people shed pounds faster than diet and exercise alone. But quitting these meds can lead to quick weight regain. Research from the University of Oxford found that people who stop GLP-1 drugs often gain back almost a pound every month

health

A New Hope in the Fight Against Obesity: The Wegovy Pill Arrives

January 5, 2026

The U. S. is seeing a big change in how obesity is treated. Novo Nordisk has just launched the first-ever GLP-1 pill for weight loss. This pill, called Wegovy, is a game-changer because it's much cheaper than the usual weekly injections. The price ranges from $149 to $299 per month, depending on the

health

Food as Medicine: A Fresh Approach to Youth Obesity Treatment

December 9, 2025

Obesity in young people is a pressing issue. It's not just about looks. It can lead to serious health problems. Doctors often prescribe medications to help. But these meds can have side effects. They might cause poor nutrition. This is a big problem. Young people may not stick to their treatment pla

health

Understanding Why Weight Loss is Hard and How to Make It Stick

November 21, 2025

The body has a clever way of keeping weight within a certain range. It does this by using hormones to control hunger and energy use. When someone eats less, the body fights back. It slows down metabolism and makes a person feel hungrier. This is why losing weight and keeping it off is so tough. Obe

health

Big Pharma Makes a Deal: Cheaper Drugs for Medicare

November 4, 2025

Two major drug companies, Lilly and Novo Nordisk, are close to striking a deal with the White House. They want to offer their weight loss drugs at a lower price. This is big news because it could mean more people can afford these medicines. The plan is to sell the lowest dose of their obesity drugs

health

Slimming Down: Can Ultrasound and Electric Currents Boost Workout Results?

July 12, 2025

By 2035, more than half of the planet's people might be overweight or obese. That's a big problem, but there's hope. Exercise, especially high-intensity interval training (HIIT), can help manage weight and improve health. But what if we could give workouts a little extra oomph? Enter therapeutic ul